AVIR (Atea Pharmaceuticals) Short Ratio


AVIR Atea Pharmaceuticals Inc AVIR
28 GF Score
Price $4.98
! 3 Warning Signs
View Full Analysis

What is Atea Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

AVIR
28GF Score
Atea Pharmaceuticals Inc AVIR
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atea Pharmaceuticals Business Description

Address 225 Franklin Street, Suite 2100, Boston, MA, USA, 02110
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
28GF Score

Get the complete analysis for AVIR

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.98
Price